Congress Holds Hearing on FDA

In fall out from the Avandia story, the House Committee on Oversight and Government Reform held a hearing yesterday on the FDA’s role in evaluating drug safety.  The NY Times has a full report.  In a prepared statement, the FDA Commissioner stated that more prominent warnings of heart risk would be required on Avandia. 

– SBS